NEW DELHI —
The World Well being Group has granted an emergency use licence to a coronavirus vaccine developed in India, providing reassurance for a shot the nation’s regulators approved lengthy earlier than superior security and efficacy testing was accomplished.
In a press release on Wednesday, the UN well being company stated it had approved Covaxin, made by India’s Bharat Biotech. The motion makes Covaxin the eighth COVID-19 vaccine to obtain WHO’s inexperienced gentle.
Covaxin was developed by Bharat Biotech in partnership with the Indian Council of Medical Analysis, the federal government’s apex analysis physique. The vaccine is made utilizing a killed coronavirus to immediate an immune response and is given in two doses.
India’s drug regulator approved Covaxin in January, months earlier than intensive testing in individuals had been accomplished, prompting concern from well being specialists that the shot was given the nod prematurely.
